Objectives: To assess the efficacy and tolerability of valsartan and valsartan plus hydrochlorothiazide (HCTZ), given alone or as part of a combination regimen with other antihypertensive agents ...
In the valsartan/HCTZ PMS study (trial 2), 28 440 patients were recruited by 9546 GPs. A total of 497 (1.9%) patients in trial 1 and 435 (1.5%) patients in trial 2 were excluded from the final ...
is recalling all lots of Valsartan Tablets, 40 mg, 80mg, 160mg, and 320mg; and Valsartan-Hydrochlorothiazide Tablets, 80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg, and 320mg/25mg to the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果